A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C.

dc.contributor.author

Reinoso, Tyler R

dc.contributor.author

Landim-Vieira, Maicon

dc.contributor.author

Shi, Yun

dc.contributor.author

Johnston, Jamie R

dc.contributor.author

Chase, P Bryant

dc.contributor.author

Parvatiyar, Michelle S

dc.contributor.author

Landstrom, Andrew P

dc.contributor.author

Pinto, Jose R

dc.contributor.author

Tadros, Hanna J

dc.date.accessioned

2020-12-27T20:21:32Z

dc.date.available

2020-12-27T20:21:32Z

dc.date.issued

2020-11-11

dc.date.updated

2020-12-27T20:21:31Z

dc.description.abstract

Familial cardiomyopathy is an inherited disease that affects the structure and function of heart muscle and has an extreme range of phenotypes. Among the millions of affected individuals, patients with hypertrophic (HCM), dilated (DCM), or left ventricular non-compaction (LVNC) cardiomyopathy can experience morphologic changes of the heart which lead to sudden death in the most detrimental cases. TNNC1, the gene that codes for cardiac troponin C (cTnC), is a sarcomere gene associated with cardiomyopathies in which probands exhibit young age of presentation and high death, transplant or ventricular fibrillation events relative to TNNT2 and TNNI3 probands. Using GnomAD, ClinVar, UniProt and PhosphoSitePlus databases and published literature, an extensive list to date of identified genetic variants in TNNC1 and post-translational modifications (PTMs) in cTnC was compiled. Additionally, a recent cryo-EM structure of the cardiac thin filament regulatory unit was used to localize each functionally studied amino acid variant and each PTM (acetylation, glycation, s-nitrosylation, phosphorylation) in the structure of cTnC. TNNC1 has a large number of variants (> 100) relative to other genes of the same transcript size. Surprisingly, the mapped variant amino acids and PTMs are distributed throughout the cTnC structure. While many cardiomyopathy-associated variants are localized in α-helical regions of cTnC, this was not statistically significant χ2 (p = 0.72). Exploring the variants in TNNC1 and PTMs of cTnC in the contexts of cardiomyopathy association, physiological modulation and potential non-canonical roles provides insights into the normal function of cTnC along with the many facets of TNNC1 as a cardiomyopathic gene.

dc.identifier

10.1007/s10974-020-09592-5

dc.identifier.issn

0142-4319

dc.identifier.issn

1573-2657

dc.identifier.uri

https://hdl.handle.net/10161/21939

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Journal of muscle research and cell motility

dc.relation.isversionof

10.1007/s10974-020-09592-5

dc.subject

Cardiac troponin C (cTnC)

dc.subject

Cardiomyopathy

dc.subject

Genetic variant

dc.subject

Heart

dc.subject

Post-translational modification

dc.subject

TNNC1

dc.title

A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C.

dc.type

Journal article

duke.contributor.orcid

Landstrom, Andrew P|0000-0002-1878-9631

pubs.organisational-group

School of Medicine

pubs.organisational-group

Cell Biology

pubs.organisational-group

Pediatrics, Cardiology

pubs.organisational-group

Duke

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Pediatrics

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020 - TNNC1 Cardiomyopathy Variants Metanalysis.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format